29160 Federal Register / Vol. 66, No. 103 / Tuesday, May 29, 2001 / Notices

Time: 10 a.m. to 1 p.m.

Place: Neuroscience Center, National

Institutes of Health, 6001 Executive Blvd.,

Rockville, MD 20852 (Telephone Conference

Call).

Contact Person: Richard C. Harrison, Chief,

Contract Review Branch, Office of Extramural

Affairs, National Institute on Drug Abuse,

National Institutes of Health, 6001 Executive

Boulevard, Room 3158, MSC 9547, Bethesda,

MD 20892–9547, 302–435–1437.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.277, Drug Abuse Scientist

Development Award for Clinicians, Scientist

Development Awards, and Research Scientist

Awards; 93.278, Drug Abuse National

Research Service Awards for Research

Training; 93.279, Drug Abuse Research

Programs, National Institutes of Health, HHS)

Dated: May 22, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–13342 Filed 5–25–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Drug Abuse;

Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National

Institute on Drug Abuse Special

Emphasis Panel, Health & Development

Consequences of Prenatal Exposure to

Methamphetamine.

Date: June 15, 2001.

Time: 12:30 p.m. to 4:30 p.m.

Agenda: To review and evaluate grant

applications.

Place: Radisson Barcelo Hotel, 2121 P

Street NW., Washington, DC 20037.

Contact Person: Kesinee Nimit, MD,

Health Scientist Administrator, Office of

Extramural Affairs, National Institute on

Drug Abuse, National Institutes of

Health, DHHS, 6001 Executive

Boulevard, Room 3158, MSC 9547,

Bethesda, MD 20892–9547, (301) 435–

1432.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.277, Drug Abuse Scientist

Development Award for Clinicians, Scientist

Development Awards, and Research Scientist

Awards; 93.278, Drug Abuse National

Research Service Awards for Research

Training; 93.279, Drug Abuse Research

Programs, National Institutes of Health,

HHS).

Dated: May 22, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–13343 Filed 5–25–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Center for Scientific Review; Notice of

Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: June 7–8, 2001.

Time: 8:30 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Clarion Hampshire Hotel, 1310 New

Hampshire Ave, NW., Washington, DC

20036.

Contact Person: Jay Joshi, Ph.D, Scientific

Review Administrator, Center for Scientific

Review, National Institutes of Health, 6701

Rockledge Drive, Room 5184, MSC 7846,

Bethesda, MD 20892, (301) 435–1184.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Oncological Sciences

Integrated Review Group Chemical Pathology

Study Section.

Date: June 11–13, 2001.

Time: 8:00 a.m. to 5:00 p.m.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn Georgetown, 2101

Wisconsin Avenue, NW., Washington, DC

20007.

Contact Person: Victor A. Fung, Ph.D,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4120,

MSC 7804, Bethesda, MD 20892, (301) 435–

3504, fungv@csr.nih.gov.

Name of Committee: Integrative,

Functional and Cognitive Neuroscience

Integrated Review Group Alcohol and

Toxicology Subcommittee 3.

Date: June 11–12, 2001.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn, 5520 Wisconsin Ave,

Chevy Chase, MD 20815.

Contact Person: Christine Melchior, Ph.D,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4102,

MSC 7816, Bethesda, MD 20892, (301) 435–

1713.

Name of Committee: Endocrinology and

Reproductive Sciences Integrated Review

Group Reproductive Endocrinology Study

Section.

Date: June 11–12, 2001.

Time: 8 a.m. to 3 p.m.

Agenda: To review and evaluate grant

applications.

Place: Courtyard By Marriott, 805 Russell

Avenue, Gaithersburg, MD 20879.

Contact Person: Abubakar A. Shaikh, DVM,

Ph.D, Scientific Review Administrator,

Center for Scientific Review, National

Institutes of Health, 6701 Rockledge Drive,

Room 6166, MSC 7892, Bethesda, MD 20892,

(301) 435–1042.

Name of Committee: Molecular, Cellular

and Developmental Neuroscience Integrated

Review Group Molecular, Cellular and

Developmental Neurosciences 3.

Date: June 11–12, 2001.

Time: 8 a.m. to 6 p.m.

Agenda: To review and evaluate grant

applications.

Place: Embassy Suites, Chevy Chase

Pavilion, 4300 Military Rd., Wisconsin at

Western Ave, Washington, DC 20015.

Contact Person: Michael A. Lang, Ph.D,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5210,

MSC 7850, Bethesda, MD 20892, (301) 435–

1265.

Name of Committee: Musculoskeletal and

Dental Sciences Integrated Review Group

General Medicine A Subcommittee 1.

Date: June 11–12, 2001.

Time: 8 a.m. to 2 p.m.

Agenda: To review and evaluate grant

applications.

Place: Ramada Inn Rockville, 1775

Rockville Pike, Rockville, MD 20852.

Contact Person: Harold M. Davidson, Ph.D,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4216,

MSC 7814, Bethesda, MD 20892, (301) 435–

1776, davidsoh@csr.nih.gov.

Federal Register / Vol. 66, No. 103 / Tuesday, May 29, 2001 / Notices 29161

Name of Committee: Pathophysiological

Sciences Integrated Review Group General

Medicine A Subcommittee 2.

Date: June 11–12, 2001.

Time: 8:30 a.m. to 5:00 p.m.

Agenda: To review and evaluate grant

applications.

Place: Monarch Hotel, 2400 M Street, NW.,

Washington, DC 20037.

Contact Person: Mushtaq A. Khan, DVM,

PhD, Scientific Review Administrator, Center

for Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 2176,

MSC 7818, Bethesda, MD 20892, 301–435–

1778, khanm@csr.nih.gov.

Name of Committee: Social Sciences,

Nursing, Epidemiology and Methods

Integrated Review Group Epidemiology and

Disease Control Subcommittee 1.

Date: June 11–12, 2001.

Time: 9 a.m. to 4 p.m.

Agenda: To review and evaluate grant

applications.

Place: Bethesda Holiday Inn, 8120

Wisconsin Avenue, Bethesda, MD 20852.

Contact Person: J. Scott Osborne, PhD,

MPH, Scientific Review Administrator,

Center for Scientific Review, National

Institutes of Health, 6701 Rockledge Drive,

Room 4114, MSC 7816, Bethesda, MD 20892,

(301) 435–1782.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: June 11, 2001.

Time: 12:30 p.m. to 1:30 p.m.

Agenda: To review and evaluate grant

applications.

Place: Courtyard By Marriott, 805 Russell

Avenue, Gaithersburg, MD 20879.

Contact Person: Abubakar A. Shaikh, DVM,

PhD, Scientific Review Administrator, Center

for Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 6166,

MSC 7892, Bethesda, MD 20892, (301) 435–

1042, shaikha@csr.nih.gov.

Name of Committee: Pathophysiological

Sciences Integrated Review Group Lung

Biology and Pathology Study Section.

Date: June 12–13, 2001.

Time: 8 a.m. to 6 p.m.

Agenda: To review and evaluate grant

applications.

Place: One Washington Circle Hotel,

Conference Center, One Washington Circle,

Washington, DC 20037.

Contact Person: George M. Barnas, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 2180,

MSC 7818, Bethesda, MD 20892, (301) 435–

0696. george_barnas@nih.gov.

Name of Committee: Cell Development and

Function Integrated Review Group Cell

Development and Function 3.

Date: June 12–13, 2001.

Time: 8:30 a.m. to 3 p.m.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn, 8120 Wisconsin

Avenue, Bethesda, MD 20814.

Contact Person: Gerhard Ehrenspeck, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5138,

MSC 7840, Bethesda, MD 20892, (301) 435–

1022.ehrenspeckg@nih.crs.gov.

Name of Committee: Cardiovascular

Sciences Integrated Review Group Pathology

A Study Section.

Date: June 12–13, 2001.

Time: 8:30 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: One Washington Circle Hotel,

Conference Center, One Washington Circle,

Washington, DC 20037.

Contact Person: Larry Pinkus, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4132,

MSC 7802, Bethesda, MD 20892, (301) 435–

1214.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: June 12, 2001.

Time: 8:30 a.m. to 12 p.m.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn Bethesda, 8120

Wisconsin Avenue, Bethesda, MD 20814.

Contact Person: Bill Bunnag, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5124,

MSC 7854, Bethesda, MD 20892–7854, (301)

435–1177, bunnagb@csr.nih.gov.

Name of Committee: Integrative,

Functional and Cognitive Neuroscience

Integrated Review Group Integrative,

Functional and Cognitive Neuroscience 5.

Date: June 12–13, 2001.

Time: 8:30 a.m. to 5:30 p.m.

Agenda: To review and evaluate grant

applications.

Place: Governor’s House Hotel, 17th &

Rhode Island Avenue, NW., Washington, DC

20036.

Contact Person: John Bishop, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5180,

MSC 7844, Bethesda, MD 20892, (301) 435–

1250.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: June 12, 2001.

Time: 1:30 a.m. to 4 p.m.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn Bethesda, 8120

Wisconsin Avenue, Bethesda, MD 20814.

Contact Person: Bill Bunnag, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5124,

MSC 7854, Bethesda, MD 20892–7854, (301)

435–1177, bunnagb@csr.nih.gov.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: June 13, 2001.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn—Chevy Chase, 5520

Wisconsin Avenue, Bethesda, MD 20815.

Contact Person: Gopal C. Sharma, DVM,

MS, PhD, Diplomate American Board of

Toxicology, Scientific Review Administrator,

Center for Scientific Review, National

Institutes of Health, 6701 Rockledge Drive,

Room 2184, MSC 7818, Bethesda, MD 20892,

(301) 435–1783, sharmag@csr.nih.gov.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: June 13, 2001.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn Bethesda, 8120

Wisconsin Avenue, Bethesda, MD 20814.

Contact Person: Bill Bunnag, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5124,

MSC 7854, Bethesda, MD 20892–7854, (301)

435–1777 bunnagb@csr.nih.gov.

Name of Committee: Integrative,

Functional and Cognitive Neuroscience

Integrated Review Group Visual Sciences B

Study Section.

Date: June 13–14, 2001.

Time: 8:30 a.m. to 4:00 p.m.

Agenda: To review and evaluate grant

applications.

Place: Georgetown Holiday Inn, 2101

Wisconsin Avenue, NW, Washington, DC

20007.

Contact Person: Christine Melchior, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4102,

MSC 7816, Bethesda, MD 20892, (301) 435–

1713.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: June 13, 2001.

Time: 3:00 p.m. to 5:00 p.m.

Agenda: To review and evaluate grant

applications.

Place: NIH, Rockledge 2, Bethesda, MD

20892, (Telephone Conference Call).

Contact Person: Paul K. Strudler, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4100,

MSC 7804, Bethesda, MD 20892, (301) 435–

1716.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: June 13, 2001.

Time: 7:30 p.m. to 9:30 p.m.

Agenda: To review and evaluate grant

applications.

Place: Washington Plaza Hotel, 10 Thomas

Circle, NW, Washington, DC 20005.

Contact Person: Alec S. Liacouras, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5154,

MSC 7842, Bethesda, MD 20892, (301) 435–

1740.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: June 14–15, 2001.

Time: 8:00 a.m. to 5:00 p.m.

Agenda: To review and evaluate grant

applications.

Place: Club Quarters DC, 839 17th Street,

NW., Washington, DC 20006.

Contact Person: Nancy Hicks, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 3158,

MSC 7770, Bethesda, MD 20892, (301) 435–

0695.

Name of Committee: Molecular, Cellular

and Development Neuroscience Integrated

29162 Federal Register / Vol. 66, No. 103 / Tuesday, May 29, 2001 / Notices

Review Group Molecular, Cellular and

Development Neurosciences 7.

Date: June 14–15, 2001.

Time: 8:00 a.m. to 5:00 p.m.

Agenda: To review and evaluate grant

applications.

Place: Doyle Washington Hotel, 1500 New

Hampshire Ave., NW, Washington, DC

20036.

Contact Person: Joanne T. Fujii, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5218,

Bethesda, MD 20892, (301) 435–1178,

fujii@drg.nih.gov.

Name of Committee: Genetic Sciences

Integrated Review Group Mammalian

Genetics Study Section.

Date: June 14–15, 2001.

Time: 8:00 a.m. to 5:00 p.m.

Agenda: To review and evaluate grant

applications.

Place: Governor’s House, 1615 Rhode

Island Avenue, NW, Washington, DC 20036.

Contact Person: Camilla Day, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 2208,

MSC 7890, Bethesda, MD 20892, (301) 435–

1037, dayc@csr.nih.gov.

Name of Committee: Cardiovascular

Sciences Integrated Review Group

Hematology Subcommittee 1.

Date: June 14–15, 2001.

Time: 8:00 a.m. to 4:00 p.m.

Agenda: To review and evaluate grant

applications.

Place: Chevy Chase Holiday Inn, Terrace

Room, 5520 Wisconsin Avenue, Chevy

Chase, MD 20815.

Contact Person: Robert Su, PhD, Scientific

Review Administrator, Center for Scientific

Review, National Institutes of Health, 6701

Rockledge Drive, Room 4134, MSC 7802,

Bethesda, MD 20892, (301) 435–1195.

Name of Committee: Immunological

Sciences Integrated Review Group

Experimental Immunology Study Section.

Date: June 14–15, 2001.

Time: 8:30 a.m. to 2:30 p.m.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn Bethesda, 8120

Wisconsin Avenue, Bethesda, MD 20814.

Contact Person: Cathleen L. Cooper, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4208,

MSC 7812, Bethesda, MD 30892, (301) 435–

3566, cooperc@csr.nih.gov.

Name of Committee: Biophysical and

Chemical Sciences Integrated Review Group

Metallobiochemistry Study Section.

Date: June 14–15, 2001.

Time: 8:30 a.m. to 6:30 p.m.

Agenda: To review and evaluate grant

applications.

Place: Georgetown Suites, 1000 29th St.,

NW., Washington, DC 20007.

Contact Person: John L. Bowers, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4168,

MSC 7806, Bethesda, MD 20892, (301) 435–

1725.

Name of Committee: Integrative,

Functional and Cognitive Neuroscience

Integrated Review Group Integrative,

Functional and Cognitive Neuroscience 7.

Date: June 14–15, 2001.

Time: 8:30 a.m. to 5:00 p.m.

Agenda: To review and evaluate grant

applications.

Place: One Washington Circle Hotel,

Conference Center, One Washington Circle,

Washington, DC 20037.

Contact Person: Bernard F. Driscoll, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5158,

MSC 7844, Bethesda, MD 20892, (301) 435–

1242.

Name of Committee: Cell Development and

Function Integrated Review Group Cell

Development and Function 1.

Date: June 14–15, 2001.

Time: 8:30 a.m. to 5:00 p.m.

Agenda: To review and evaluate grant

applications.

Place: Georgetown Suites, 1000 29th St.,

NW., Washington, DC 20007.

Contact Person: Michael H. Sayre, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5128,

Bethesda, MD 20892, (301) 435–1219.

Name of Committee: Infectious Diseases

and Microbiology Integrated Review Group

Tropical Medicine and Parasitology Study

Section.

Date: June 14–15, 2001.

Time: 8:30 a.m. to 5:00 p.m.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn Bethesda, 8120

Wisconsin Avenue, Bethesda, MD 20814.

Contact Person: Jean Hickman, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4194,

MSC 7808, Bethesda, MD 20892, (301) 435–

1146.

Name of Committee: Oncological Sciences

Integrated Review Group Experimental

Therapeutics Subcommittee 1.

Date: June 14–15, 2001.

Time: 8:30 a.m. to 5:00 p.m.

Agenda: To review and evaluate grant

applications.

Place: Hyatt-Arlington at Washington’s Key

Bridge, 1325 Wilson Boulevard, Arlington,

VA 22209–9990.

Contact Person: Philip Perkins, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4148,

MSC 7804, Bethesda, MD 20892, (301) 435–

1718, perkinsp@csr.nih.gov.

Name of Committee: Biochemical Sciences

Integrated Review Group Biochemistry Study

Section.

Date: June 14–15, 2001.

Time: 8:30 a.m. to 3:00 p.m.

Agenda: To review and evaluate grant

applications.

Place: Hotel Sofitel, 1914 Connecticut Ave,

NW., Washington, DC 20009.

Contact Person: Chhanda L. Ganguly, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5156,

MSC 7842, Bethesda, MD 20892, (301) 435–

1739.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: June 14–15, 2001.

Time: 8:30 a.m. to 4:30 p.m.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn Central, 1501 Rhode

Island Ave, NW., Washington, DC 20005.

Contact Person: Carl D. Banner, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5212,

MSC 7850, Bethesda, MD 20892, (301) 435–

1251, bannerc@drg.nih.gov.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: June 14–15, 2001.

Time: 9:00 a.m. to 5:00 p.m.

Agenda: To review and evaluate grant

applications.

Place: Governor’s House Hotel, 17th &

Rhode Island Avenue, NW., Washington, DC

20036.

Contact Person: Anita Miller Sostek, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 3176,

MSC 7848, Bethesda, MD 20892, (301) 435–

1260.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: June 14–15, 2001.

Time: 9:00 a.m. to 5:30 p.m.

Agenda: To review and evaluate grant

applications.

Place: St James Suites, 950 24th Street,

NW., Washington, DC 20037.

Contact Person: Ellen K. Schwartz, EDD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 3168,

MSC 7770, Bethesda, MD 20892, (301) 435–

0681, schwarte@csr.nih.gov.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: June 14–15, 2001.

Time: 9:00 a.m. to 5:00 p.m.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn, 5520 Wisconsin

Avenue, Chevy Chase, MD 20815.

Contact Person: Richard Marcus, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5168,

MSC 7844, Bethesda, MD 20892, 301–435–

1245, richard.marcus@nih.gov.

Name of Committee: Genetic Sciences

Integrated Review Group Genetics Study

Section.

Date: June 14–16, 2001.

Time: 9:00 a.m. to 4:00 p.m.

Agenda: To review and evaluate grant

applications.

Place: The River Inn, 924 25th St NW.,

Washington, DC 20037.

Contact Person: David J. Remondini, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 6154,

MSC 7890, Bethesda, MD 20892, (301) 435–

1038, remondid@csr.nih.gov.

Federal Register / Vol. 66, No. 103 / Tuesday, May 29, 2001 / Notices 29163

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: June 14–15, 2001.

Time: 9:00 a.m. to 6:00 p.m.

Agenda: To review and evaluate grant

applications.

Place: Radisson Barcelo, 2121 P Street,

NW., Washington, DC 20037.

Contact Person: Victoria S. Levin, MSW,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 3172,

MSC 7848, Bethesda, MD 20892, (301) 435–

0912, levinv@csr.nih.gov.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: June 15, 2001.

Time: 1:00 p.m. to 5:00 p.m.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn, 8120 Wisconsin

Avenue, Bethesda, MD 20814.

Contact Person: Paul D. Wagner, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5194,

MSC 7840, Bethesda, MD 20892, (301) 435–

6809, wagnerp@csr.nih.gov.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.306, Comparative Medicine,

93.306; 93.333, Clinical Research, 93.333,

93.337, 93.393–93.396, 93.837–93.844,

93.846–93.878, 93.892, 93.893, National

Institutes of Health, HHS)

Dated: May 22, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–13332 Filed 5–25–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF THE INTERIOR

Bureau of Land Management

[CA–650–01–1220–JG–064B]

Closure Order for Motorized Vehicle

Use, Surprise Canyon Area of Critical

Environmental Concern BLM Route

P71, Panamint Mountains, Inyo

County, CA

AGENCY: Bureau of Land Management,

United States Department of the

Interior.

ACTION: Notice of vehicle closure on

BLM Route P71 in the Surprise canyon

area of critical environmental concern,

Panamint Mountains in Inyo County,

California.

SUMMARY: Notice is hereby given that

BLM Route P71 is closed to motorized

vehicle use within the Surprise Canyon

Area of Critical Environmental Concern

(ACEC).

Order: The public lands from a point

located in the vicinity of Chris Wicht

Camp approximately four miles east of

the intersection of BLM Route P71 and

the Indian Ranch/Wingate Road to the

boundary of Death Valley National Park

within the Surprise Canyon ACEC is

hereby closed to all motorized vehicle

use. No person may use, drive,

transport, park, let stand, or have charge

or control over any motorized vehicle in

the area located east of the closure signs

and the BLM locked gate. Exemptions to

this order may be granted to law

enforcement and other emergency

vehicles in the course of official duties.

Exemptions to this order may be granted

to the holders of private property in the

vicinity of Panamint City in Death

Valley National Park for reasonable

access after receiving a written

agreement and a key from the Ridgecrest

Field Office Manager.

EFFECTIVE DATE: This closure is effective

upon publication in the Federal

Register and will remain in effect until

rescinded by the authorizing official

which will occur when a final decision

on the disposition of the road will be

made after the National Environmental

Policy Act and California Desert

Conservation Area Plan amendment

processes are completed. BLM will

implement the proposed action effective

the date of publication in the Federal

Register, without prior notice and

opportunity for public comment,

because of the imminent need for

regulatory authority to prevent illegal/

unauthorized vehicle intrusion into the

Surprise Canyon Wilderness and

potential risk to aquatic/riparian

resources.

FOR FURTHER INFORMATION CONTACT:

Field Office Manager, Bureau of Land

Management, Ridgecrest Field Office,

300 South Richmond Road, Ridgecrest

CA 93555, (760) 384–5405.

SUPPLEMENTARY INFORMATION: In March

16, 2000, the Center for Biological

Diversity, et al. (Center) filed for

injunctive relief in U.S. District Court,

Northern District of California (Court)

against the Bureau of Land Management

(BLM) to immediately prohibit all

grazing activities that may affect listed

species. The Center alleges the BLM was

in violation of section 7 of the

Endangered Species Act (ESA) by failing

to enter into formal consultation with

the U.S. Fish and Wildlife Service

(FWS) on the effects of adoption of the

California Desert Conservation Area

Plan (CDCA Plan), as amended, upon

threatened and endangered species. On

August 25, 2000, the BLM

acknowledged through a court

stipulation that activities authorized,

permitted, or allowed under the CDCA

Plan may adversely affect threatened

and endangered species, and that the

BLM is required to consult with the

FWS to insure that adoption and

implementation of the CDCA Plan is not

likely to jeopardize the continued

existence of threatened and endangered

species or to result in the destruction or

adverse modification of critical habitat

of listed species.

Although BLM has received biological

opinions on selected activities,

consultation on the overall CDCA Plan

is necessary to address the cumulative

effects of all the activities authorized by

the CDCA Plan. Consultation on an

overall plan is complex and the

completion date uncertain. Absent

consultation on the entire plan, the

impacts of individual activities, when

added together with the impacts of other

activities in the desert, are not known.

The BLM entered into negotiations with

plaintiffs regarding interim actions to be

taken to provide protection for

endangered and threatened species

pending completion of consultation on

the plan. Agreement on these interim

actions avoided litigation of plaintiffs’

request for injunctive relief and the

threat of an injunction prohibiting all

activities authorized under the plan.

These interim agreements allowed BLM

to continue appropriate levels of activity

throughout the planning area during the

lengthy consultation process while

providing protection to the desert

tortoise and other listed species in the

short term. By taking interim actions as

allowed under 43 CFR 8364.1, BLM

contributes to the conservation of the

endangered and threatened species in

accordance with 7 (a)(1) of the ESA.

BLM also avoids making any

irreversible or irretrievable commitment

of resources which would foreclose any

reasonable and prudent alternatives

which might be required as a result of

the consultation on the CDCA Plan in

accordance with 7(d) for the ESA. In

January 2001, the parties signed the

Stipulation and Proposed Order

concerning All Further Injunctive

Relief.

This closure order is issued to provide

interim protection of riparian habitat,

water quality, sensitive wildlife

resources, and wilderness values within

the Surprise Canyon ACEC until such a

time when the BLM completes a

thorough review and analysis of various

methods of access in Surprise Canyon

and complies with the processes

required by the National Environmental

Policy Act and the California Desert

Conservation Area Plan. This interim

closure will allow BLM to properly

evaluate and arrive at a final decision on

environmentally acceptable methods of

access in Surprise Canyon while

protecting the canyon from further

impact caused by the operation of offVerDate 11<MAY>2000 17:37 May 25, 2001 Jkt 194001 PO 00000 Frm 00089 Fmt 4703 Sfmt 4703 E:\FR\FM\29MYN1.SGM pfrm11 PsN: 29MYN1